PRIMARY STUDY
The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD
Key Findings: MDMA-assisted therapy had a greater reduction in Alcohol Use Disorder Identification Test scores than placebo, but no difference in scores for the Drug Use Disorder Identification Test in MDMA-assisted versus placebo therapy.
Type of Study: Double Blind Clinical Trial
Study Sample Size: 90
Study Result: Positive
Research Location(s): United States
Year of Pub: 2022
Cannabinoids Studied: Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Citation: Nicholas CR, et al. The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD. Drug Alcohol Depend. 2022; 233:109356. doi: 10.1016/j.drugalcdep.2022.109356
Authors: Nicholas CR, Wang JB, Coker A, Mitchell JM, Klaire SS, Yazar-Klosinski B, Emerson A, Brown RT, Doblin R
